NCT03628209 Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03356782 Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas Status RECRUITING Phase PHASE1/PHASE2
NCT03282344 A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03261544 Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method? Status RECRUITING Phase N/A
NCT03069378 A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02846987 Study of Abemaciclib in Dedifferentiated Liposarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02390752 Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... Status RECRUITING Phase PHASE1
NCT02298959 Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01875601 NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01109394 Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies Status RECRUITING Phase N/A
NCT00579566 Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma Status RECRUITING Phase N/A